Genome-Wide Gene Expression Profile Analyses Identify CTTN as a Potential Prognostic Marker in Esophageal Cancer

Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival

(2017) Cecilia Folio et al.   Cancer Biomarkers

Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma

(2013) Gang Zhao et al.   World Journal of Surgical Oncology

A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma

(2011) Lin-wei Li et al.   BMC CANCER

Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody-dependent cellular cytotoxicity of EGFR- and HER2-overexpressing esophageal cancer cell lines

(2011) Kousaku Mimura et al.   INTERNATIONAL JOURNAL OF CANCER

Differential Gene Expression in Oligodendrocyte Progenitor Cells, Oligodendrocytes and Type II Astrocytes

(2011) Jian-Guo Hu et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

Cortactin

(2011) Kellye C. Kirkbride et al.   Cell Adhesion & Migration

Cancer Trends in China

(2010) P. Zhao et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Esophageal cancer: An update

(2010) C.M. Shahbaz Sarwar et al.   International Journal of Surgery

Early diagnosis of oesophageal cancer

(2009) E L Bird-Lieberman et al.   BRITISH JOURNAL OF CANCER

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growthin vitroandin vivo

(2009) Lin-Wei Li et al.   INTERNATIONAL JOURNAL OF CANCER